Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger-Ellison syndrome and antral G-cell hyperfunction / Annibale, B., DELLE FAVE, G., Azzoni, C., Corleto, V.D., Camboni, G., D'Ambra, G., Pilato, F.p., Bordi, C.. - In: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. - ISSN 0269-2813. - 8:(1994), pp. 95-104.
Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger-Ellison syndrome and antral G-cell hyperfunction.
ANNIBALE, Bruno;DELLE FAVE, Gianfranco;CORLETO, Vito Domenico;D'AMBRA, Giancarlo;
1994
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
